Literature DB >> 24771873

Response.

Ian E Haines1, George L Gabor Miklos2.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24771873      PMCID： PMC4677262          DOI： 10.1093/jnci/dju081

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  11 in total

1.  Re: Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection.

Authors:  Patrick C Walsh
Journal:  J Natl Cancer Inst       Date:  2014-01-07       Impact factor: 13.506

2.  Change of tumour characteristics and treatment over time in both arms of the European Randomized study of Screening for Prostate Cancer.

Authors:  S J Boevee; L D F Venderbos; T L J Tammela; V Nelen; S Ciatto; M Kwiatkowski; A Páez; B Malavaud; J Hugosson; M J Roobol
Journal:  Eur J Cancer       Date:  2010-11       Impact factor: 9.162

Review 3.  Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.

Authors:  Roger Chou; Jennifer M Croswell; Tracy Dana; Christina Bougatsos; Ian Blazina; Rongwei Fu; Ken Gleitsmann; Helen C Koenig; Clarence Lam; Ashley Maltz; J Bruin Rugge; Kenneth Lin
Journal:  Ann Intern Med       Date:  2011-10-07       Impact factor: 25.391

4.  Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.

Authors:  Jonas Hugosson; Sigrid Carlsson; Gunnar Aus; Svante Bergdahl; Ali Khatami; Pär Lodding; Carl-Gustaf Pihl; Johan Stranne; Erik Holmberg; Hans Lilja
Journal:  Lancet Oncol       Date:  2010-07-02       Impact factor: 41.316

5.  RE: Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection.

Authors:  Sigrid Carlsson; Monique J Roobol; Fritz H Schröder; Jonas Hugosson; Anssi Auvinen
Journal:  J Natl Cancer Inst       Date:  2014-04-26       Impact factor: 13.506

6.  Prostate-cancer mortality at 11 years of follow-up.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Alvaro Páez; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Sigrid Carlsson; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Paula M Kujala; Bert G Blijenberg; Ulf-Hakan Stenman; Andreas Huber; Kimmo Taari; Matti Hakama; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2012-03-15       Impact factor: 91.245

7.  Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection.

Authors:  Ian E Haines; George L Gabor Miklos
Journal:  J Natl Cancer Inst       Date:  2013-10-03       Impact factor: 13.506

8.  Prostate cancer mortality in the Finnish randomized screening trial.

Authors:  Tuomas P Kilpeläinen; Teuvo L Tammela; Nea Malila; Matti Hakama; Henrikki Santti; Liisa Määttänen; Ulf-Håkan Stenman; Paula Kujala; Anssi Auvinen
Journal:  J Natl Cancer Inst       Date:  2013-03-11       Impact factor: 13.506

9.  Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial.

Authors:  Anders Widmark; Olbjørn Klepp; Arne Solberg; Jan-Erik Damber; Anders Angelsen; Per Fransson; Jo-Asmund Lund; Ilker Tasdemir; Morten Hoyer; Fredrik Wiklund; Sophie D Fosså
Journal:  Lancet       Date:  2008-12-16       Impact factor: 79.321

10.  Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial.

Authors:  Padraig Warde; Malcolm Mason; Keyue Ding; Peter Kirkbride; Michael Brundage; Richard Cowan; Mary Gospodarowicz; Karen Sanders; Edmund Kostashuk; Greg Swanson; Jim Barber; Andrea Hiltz; Mahesh K B Parmar; Jinka Sathya; John Anderson; Charles Hayter; John Hetherington; Matthew R Sydes; Wendy Parulekar
Journal:  Lancet       Date:  2011-11-02       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.